Analyst price target range
NovoCure Price Target: $27.14 Average
Direct answer
NovoCure's average price target is $27.14.
The verified analyst range runs from $17.00 to $52.00.
The low target implies +6.2%, the high target implies +224.8%, and the range spans 218.6% of the current price.
Forecast evidence checked September 23, 2026.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.01
- Average price target
- $27.14
- High price target
- $52.00
- Low price target
- $17.00
- Low target gap
- +6.2%
- Target upside
- +69.5%
- High target gap
- +224.8%
- Target range width
- 218.6%
- Consensus rating
- Buy
- Analysts
- 7
- Evidence date
- September 23, 2026
- Valid through
- September 30, 2026
Explore related company data
Read the frequently asked questions.
What is NovoCure's average price target?
NovoCure's verified average price target is $27.14. The target range is $17.00 to $52.00.
How far are NovoCure's low and high targets from the recorded price?
The low target implies +6.2%, while the high target implies +224.8%.
How many analysts are included in NovoCure's consensus?
The verified consensus includes 7 analysts.
How is NovoCure's target upside or downside calculated?
The average target of $27.14 is divided by the recorded price of $16.01, then one is subtracted to produce +69.5%. This does not guarantee a future return.
When was NovoCure's analyst forecast verified?
The data was verified on 2026-09-23. The dataset is valid through 2026-09-30.